Publications by authors named "Ruby Pandher"

Claim this Profile
H
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic.
Dannielle H Upton, Jie Liu, Sandra M George, Santosh Valvi, Caitlin Ung, Ruby Pandher

Neuro Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma.
Kimberley M Hanssen, Jayne Murray, Ruby Pandher, Stephanie Alfred, Laura D Gamble

J Exp Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response.
Ruby Pandher, Chengyuan Xue, Laura D Gamble, Giorgio Milazzo, Simone Di Giacomo

Proc Natl Acad Sci U S A· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma.
Mujahid Azfar, Weiman Gao, Chris Van den Haute, Lin Xiao, Mawar Karsa, Ruby Pandher

Mol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of histone methyltransferases EZH2 and DOT1L is an effective therapy for neuroblastoma.
Janith A Seneviratne, Daenikka Ravindrarajah, Daniel R Carter, Vicki Zhai, Amit Lalwani, Ruby Pandher

Cancer Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct targeted therapy for MLL-fusion-driven high-risk acute leukaemias.
Sandra Cantilena, Luca Gasparoli, Deepali Pal, Olaf Heidenreich, Jan-Henning Klusmann, Ruby Pandher

Clin Transl Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma.
Lin Xiao, Klaartje Somers, Jayne Murray, Ruby Pandher, Mawar Karsa

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.
Anahid Ehteda, Sandy Simon, Laura Franshaw, Federico M Giorgi, Jie Liu, Ruby Pandher

Cell Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.
Aaminah Khan, Laura D Gamble, Dannielle H Upton, Caitlin Ung, Denise M T Yu, Ruby Pandher

Nat Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction.
Klaartje Somers, Victoria W Wen, Shiloh M C Middlemiss, Brenna Osborne, Helen Forgham, Ruby Pandher

Oncogene· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis